Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRVM2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,129
Award facts
- Contract value 100% obligated
- $55,128.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,128.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on September 13, 2025, with completion targeted for September 15, 2025. This competitive award carries no set-aside designation and represents a single delivery transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's distribution center in Conshohocken, Pennsylvania.
This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive IDC to furnish specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current award of Cosentyx, a biologic immunosuppressant used to treat inflammatory conditions, demonstrates the company's role in delivering specialized pharmaceuticals critical to military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FRVM2?
SPE2DB25FRVM2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 13, 2025.
How much is contract SPE2DB25FRVM2 worth?
The government has obligated $55,129 on SPE2DB25FRVM2.
Is contract SPE2DB25FRVM2 an order under another contract?
Yes. SPE2DB25FRVM2 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRVM2 competed?
The extent of competition for SPE2DB25FRVM2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award